1. Home
  2. WST vs ARE Comparison

WST vs ARE Comparison

Compare WST & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ARE
  • Stock Information
  • Founded
  • WST 1923
  • ARE 1994
  • Country
  • WST United States
  • ARE United States
  • Employees
  • WST N/A
  • ARE N/A
  • Industry
  • WST Medical/Dental Instruments
  • ARE Real Estate Investment Trusts
  • Sector
  • WST Health Care
  • ARE Real Estate
  • Exchange
  • WST Nasdaq
  • ARE Nasdaq
  • Market Cap
  • WST 15.6B
  • ARE 12.6B
  • IPO Year
  • WST N/A
  • ARE 1997
  • Fundamental
  • Price
  • WST $216.71
  • ARE $72.60
  • Analyst Decision
  • WST Buy
  • ARE Hold
  • Analyst Count
  • WST 7
  • ARE 9
  • Target Price
  • WST $331.67
  • ARE $117.11
  • AVG Volume (30 Days)
  • WST 690.0K
  • ARE 1.7M
  • Earning Date
  • WST 07-24-2025
  • ARE 07-21-2025
  • Dividend Yield
  • WST 0.38%
  • ARE 7.27%
  • EPS Growth
  • WST N/A
  • ARE N/A
  • EPS
  • WST 6.37
  • ARE 0.76
  • Revenue
  • WST $2,895,800,000.00
  • ARE $3,111,841,000.00
  • Revenue This Year
  • WST $3.38
  • ARE N/A
  • Revenue Next Year
  • WST $5.85
  • ARE $2.72
  • P/E Ratio
  • WST $34.31
  • ARE $95.24
  • Revenue Growth
  • WST N/A
  • ARE 5.31
  • 52 Week Low
  • WST $187.43
  • ARE $67.37
  • 52 Week High
  • WST $352.33
  • ARE $130.14
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.20
  • ARE 49.53
  • Support Level
  • WST $215.67
  • ARE $70.83
  • Resistance Level
  • WST $223.77
  • ARE $75.80
  • Average True Range (ATR)
  • WST 4.99
  • ARE 1.66
  • MACD
  • WST -0.52
  • ARE 0.33
  • Stochastic Oscillator
  • WST 19.10
  • ARE 35.61

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: